27 filings
8-K
VGEN
Vaccinogen Inc
1 Jul 16
Entry into a Material Definitive Agreement
12:00am
8-K
VGEN
Vaccinogen Inc
10 Jun 16
Regulation FD Disclosure
12:00am
8-K
VGEN
Vaccinogen Inc
13 May 16
Entry into a Material Definitive Agreement
12:00am
8-K
VGEN
Vaccinogen Inc
8 Apr 16
Entry into a Material Definitive Agreement
12:00am
8-K
VGEN
Vaccinogen Inc
1 Mar 16
Entry into a Material Definitive Agreement
12:00am
8-K
cfs0jpoica
1 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
jv06bl7wwa6oqz3ikiu
18 Nov 15
Entry into a Material Definitive Agreement
12:00am
8-K
1edlmp
10 Nov 15
Departure of Directors or Certain Officers
12:00am
8-K/A
uf3f1r
28 Oct 15
Termination of a Material Definitive Agreement
12:00am
8-K
tqtd1t1
6 Oct 15
Termination of a Material Definitive Agreement
12:00am
8-K
4jp4gn
6 Oct 15
Vaccinogen Appoints Michael G. Hagerman to its Board of Directors
12:00am
8-K
ojfj6bvml6dr
5 May 15
Entry into a Material Definitive Agreement
12:00am
8-K
m57sg9020lm0hpbx0
5 May 15
Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board
12:00am
8-K
thx1zk 82625xhdcfh
24 Apr 15
Departure of Directors or Certain Officers
12:00am
8-K
1zndwcca
20 Feb 15
Departure of Directors or Certain Officers
12:00am
8-K
wsv64bn2rc 5m4b
12 Feb 15
Departure of Directors or Certain Officers
12:00am
8-K
v606p
30 Jan 15
Vaccinogen Closes Second Tranche of $80 Million Financing
12:00am
8-K
0w58tgo ry
12 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
q89f4o67 vbif
31 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
v0qqs8u7qmcxlgnjr5s
22 Sep 14
Entry into a Material Definitive Agreement
12:00am